Design Therapeutics Future Growth
Future criteria checks 0/6
Design Therapeutics's earnings are forecast to decline at 7.3% per annum while its annual revenue is expected to grow at 81.1% per year. EPS is expected to decline by 0.8% per annum.
Key information
-7.3%
Earnings growth rate
-0.8%
EPS growth rate
| Biotechs earnings growth | 20.7% |
| Revenue growth rate | 81.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 20 Mar 2024 |
Recent future growth updates
Recent updates
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans
Mar 15
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Nov 16Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation
Jun 06Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans
Feb 09Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Oct 25Design Therapeutics GAAP EPS of -$0.27 misses by $0.02
Aug 08We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate
Jul 02Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Mar 18Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Dec 03Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation
Aug 18Design Therapeutics expands board of directors
Jun 07Design Therapeutics EPS misses by $0.24
May 10Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -94 | N/A | N/A | 3 |
| 12/31/2025 | N/A | -82 | N/A | N/A | 4 |
| 12/31/2024 | N/A | -72 | N/A | N/A | 4 |
| 12/31/2023 | N/A | -67 | -59 | -59 | N/A |
| 9/30/2023 | N/A | -72 | -61 | -61 | N/A |
| 6/30/2023 | N/A | -74 | -61 | -60 | N/A |
| 3/31/2023 | N/A | -69 | -58 | -57 | N/A |
| 12/31/2022 | N/A | -63 | -52 | -51 | N/A |
| 9/30/2022 | N/A | -57 | -46 | -45 | N/A |
| 6/30/2022 | N/A | -51 | -41 | -40 | N/A |
| 3/31/2022 | N/A | -43 | -39 | -38 | N/A |
| 12/31/2021 | N/A | -36 | -31 | -29 | N/A |
| 9/30/2021 | 0 | -28 | -24 | -23 | N/A |
| 6/30/2021 | 0 | -19 | -17 | -17 | N/A |
| 3/31/2021 | 0 | -13 | -10 | -10 | N/A |
| 12/31/2020 | 0 | -8 | -9 | -9 | N/A |
| 12/31/2019 | 1 | -2 | 0 | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DSGN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DSGN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DSGN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DSGN is forecast to have no revenue next year.
High Growth Revenue: DSGN is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DSGN's Return on Equity is forecast to be high in 3 years time